-
American Journal of Clinical Pathology Sep 1993
Topics: Autoimmune Diseases; Diagnosis, Differential; Female; Humans; Hyperthyroidism; Hypothyroidism; Puerperal Disorders; Thyroiditis; Thyroiditis, Autoimmune
PubMed: 8379524
DOI: 10.1093/ajcp/100.3.193 -
Case Reports in Endocrinology 2014Thyroiditis encompasses a group of disorders characterized by thyroid inflammation. Though clinically indistinguishable from silent thyroiditis, postpartum thyroiditis...
Thyroiditis encompasses a group of disorders characterized by thyroid inflammation. Though clinically indistinguishable from silent thyroiditis, postpartum thyroiditis occurs in women within 12 months after delivery. Recurrent postpartum thyroiditis in subsequent pregnancies is common, but recurrent silent thyroiditis is rare. We reported a case of patient with recurrent episodes of thyroiditis, unrelated to pregnancy, after an episode of postpartum thyroiditis. It is of interest that postpartum thyroiditis and silent thyroiditis could occur closely to each other; however, the link between these disorders is not well established. This report is to remind physicians of the possibility of recurrent silent thyroiditis in women with a history of postpartum thyroiditis.
PubMed: 24987536
DOI: 10.1155/2014/286373 -
Acta Medica Portuguesa 2003The author refers to the main clinical symptoms, diagnosis, treatment and evaluation of the post-partum thyroiditis. Researches can reveal different post-partum...
The author refers to the main clinical symptoms, diagnosis, treatment and evaluation of the post-partum thyroiditis. Researches can reveal different post-partum thyroiditis, considering the diagnosis and screening. Normally the classical presentation of post-partum thyroiditis includes a period of thyrotoxicosis, followed by hypothyroidism and finally thyroid functions in its normal levels. According to some statistic investigation, authors mention that after a period of normal and stable status, hypothyroidism can prevail as a long-term disease.
Topics: Female; Humans; Puerperal Disorders; Thyroiditis
PubMed: 14750284
DOI: No ID Found -
Frontiers in Endocrinology 2017The year following parturition is a critical time for the appearance or exacerbation of autoimmune diseases, including autoimmune thyroid disease. The vast majority of... (Review)
Review
The year following parturition is a critical time for the appearance or exacerbation of autoimmune diseases, including autoimmune thyroid disease. The vast majority of postpartum thyroid disease consists of postpartum thyroiditis (PPT) and the minority by Graves' disease and non-autoimmune thyroiditis. PPT has a worldwide prevalence ranging from 1 to 22% and averaging 5% based on a review published in 2012. Several factors confer risk for the development of PPT. Typically, the clinical course of PPT is characterized by three phases: thyrotoxic, hypothyroid, and euthyroid phase. Approximately half of PPT women will have permanent hypothyroidism. The best humoral marker for predictivity, already during the first trimester of gestation, is considered positivity for thyroperoxidase autoantibodies (TPOAb), though only one-third to half of such TPOAb-positive pregnant women will develop PPT. Nutraceuticals (such as selenium) or omega-3-fatty acid supplements seem to have a role in prevention of PPT. In a recent study on pregnant women with stable dietary habits, we found that the fish consumers had lower rates of positivity (and lower serum levels) of both TPOAb and thyroglobulin Ab compared to meat eaters. Finally, we remind the reader of other diseases that can be observed in the postpartum period, either autoimmune or non-autoimmune, thyroid or non-thyroid.
PubMed: 28751877
DOI: 10.3389/fendo.2017.00166 -
Cureus Jan 2024Thyrotoxicosis can exhibit overlapping symptoms of psychosis in the general population. Each of these pathologies has well-established workups and management. Rare...
Thyrotoxicosis can exhibit overlapping symptoms of psychosis in the general population. Each of these pathologies has well-established workups and management. Rare presentations of thyroiditis and psychosis in the postpartum state have been seen in case studies mostly, but data on the prevalence of postpartum psychosis in association with postpartum thyroiditis are not available. Here, we present a unique case of a patient with a history of bipolar disorder who originally presented with postpartum thyroiditis that was worked up and managed appropriately. However, on follow-up, the patient was found to have progressed into prominent psychosis. Both thyroiditis and psychosis were managed individually with full remission upon discharge and is doing well today. The co-occurrence of postpartum psychosis and thyroiditis presents a unique challenge for timely diagnosis and management. We present a case of a young woman initially diagnosed with postpartum thyroiditis needing further management of postpartum psychosis due to persistent symptoms. Clinical presentation supported with a prior history of mood disorder increases the likelihood of these diagnoses together.
PubMed: 38361668
DOI: 10.7759/cureus.52357 -
The Journal of Clinical Endocrinology... Jan 1992
Review
Topics: Autoimmunity; Humans; Hypothyroidism; Puerperal Disorders; Thyroid Function Tests; Thyroiditis; Thyrotoxicosis
PubMed: 1727826
DOI: 10.1210/jcem.74.1.1727826 -
Thyroid : Official Journal of the... Oct 2011
Topics: Antibodies; Female; Humans; Hypothyroidism; Mass Screening; Postpartum Period; Postpartum Thyroiditis; Pregnancy; Pregnancy Complications; Societies, Medical; Thyroid Diseases; Thyroid Gland; United States
PubMed: 21787128
DOI: 10.1089/thy.2011.0087 -
The Journal of Clinical Endocrinology... Sep 2002
Review
Topics: Female; Humans; Prevalence; Puerperal Disorders; Thyroiditis; Time Factors
PubMed: 12213841
DOI: 10.1210/jc.2002-020524 -
Presse Medicale (Paris, France : 1983) Apr 1991Endocrine and immune system explorations, systematically performed at the end of pregnancy for the last 15 years, have shown that in about 5 percent of women delivery is... (Review)
Review
Endocrine and immune system explorations, systematically performed at the end of pregnancy for the last 15 years, have shown that in about 5 percent of women delivery is followed by thyroid dysfunction and goitrogenic episodes due to a painless or silent thyroiditis. In genetically predisposed subjects, this pathology is the expression of a hitherto asymptomatic chronic lymphocytic thyroiditis revealed by the generalized autoimmunity rebound that is characteristic of the postpartum period. Usually benign and transient, the thyroiditis may recur during subsequent pregnancies and eventually result in permanent hypothyroidism.
Topics: Female; Graves Disease; Humans; Pregnancy; Prognosis; Puerperal Disorders; Thyroiditis, Autoimmune
PubMed: 1827906
DOI: No ID Found -
Archives of Internal Medicine Jul 1990The incidence of postpartum thyroiditis (PPT) in the general population has been reported to range from 1.9% to 16.7%, depending on the study. To determine whether bias... (Review)
Review
The incidence of postpartum thyroiditis (PPT) in the general population has been reported to range from 1.9% to 16.7%, depending on the study. To determine whether bias may have played a role in the generation of these widely varying estimates, a set of methodologic criteria were applied to the published original research dealing with the epidemiology of PPT. The articles that passed these methodologic filters reported a narrow range of incidences of PPT, varying between 3.7% and 5.9%. Reanalysis of these articles confirmed that thyrotoxicosis occurred more frequently in the first 3 months post partum than did hypothyroidism, and that a positive antimicrosomal antibody titer was strongly associated with postpartum thyroid dysfunction (odds ratio, 86.6; 95% confidence interval, 45.9 to 163.2). This article suggests that PPT is a common condition that occurs in the postpartum period. The best estimate of the incidence of PPT in an unselected cohort of postpartum women is 4.9%.
Topics: Autoantibodies; Female; Humans; Incidence; Prevalence; Puerperal Disorders; Thyroiditis
PubMed: 2196025
DOI: No ID Found